Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/583
Title: Combination therapy with finasteride and low-dose dutasteride in the treatment of androgenetic alopecia.
Epworth Authors: Sinclair, Rodney
Other Authors: Boyapati, A.
Keywords: Alopecia
Hair Loss
Androgenetic Alopecia
MPHL
Male Pattern Hair Loss
MPHL
Dutasteride
Finasteride
5-alpha Reductase Inhibitors
Drug Therapy
Azasteroids
Head & Neck Clinical Institute, Epworth HealthCare, Victoria, Australia
Chair of Dermatology, Epworth HealthCare, Victoria, Australia
Issue Date: Feb-2013
Publisher: Wiley
Citation: Australas J Dermatol. 2013 Feb;54(1):49-51.
Abstract: We report on a 47-year-old man who was initially treated with finasteride for androgenetic alopecia. Despite continuous treatment, after year 4 his hair density was not as good as at year 2, and low-dose dutasteride at 0.5 mg/week was added to the finasteride therapy. This resulted in a dramatic increase in his hair density, demonstrating that combined therapy with finasteride and dutasteride can improve hair density in patients already taking finasteride.
URI: http://hdl.handle.net/11434/583
DOI: 10.1111/j.1440-0960.2012.00909.x
PubMed URL: http://www.ncbi.nlm.nih.gov/pubmed/22686691
ISSN: 1440-0960
Journal Title: Australasian Journal of Dermatology
Type: Journal Article
Affiliated Organisations: Department of Dermatology, St Vincent's Hospital Melbourne, Victoria, Australia.
Type of Clinical Study or Trial: Case reports
Appears in Collections:Head & Neck

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.